Last reviewed · How we verify
NCT06573567
Bioimpedance Analysis for Hemodialysis
NA trial testing Bioimpedance in Hemodialysis Complication in 50 participants. Completed in 11 February 2026.
11 February 2026
Quick facts
| Lead sponsor | Cishan Hospital, Ministry of Health and Welfare |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 50 |
| Start date | 1 September 2024 |
| Primary completion | 11 February 2026 |
| Estimated completion | 11 February 2026 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Bioimpedance
- Control
Conditions studied
- Hemodialysis Complication — all drugs for Hemodialysis Complication →
Sponsor
Cishan Hospital, Ministry of Health and Welfare
Who can join
18 and older, any sex, with Hemodialysis Complication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to learn if bioimpedance-guided fluid management can help decrease hemodialysis complications. The main questions it aims to answer are: Does bioimpedance-guided fluid management decrease major cardiovascular events? Does bioimpedance-guided fluid management decrease other hemodialysis complications? Participants will: Take bioimpedance analysis once per month Adjust dry weight according to the analysis as possible in active group Blind the analysis results to the doctor and the patient in the control group
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06573567
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Bioimpedance
Trials testing the same drug.
- NCT06114498 — Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction · active not recruiting
- NCT04645121 — Carbon Monoxide-based Rebreathing Method and Bioimpedance in Hemodialysis Patients · completed
- NCT03942432 — A Prospective, Mono-center, Interventional Study Evaluating the Effect of One Year Initial Care by Hygieno-dietary Advic · NA · completed
- NCT03454711 — Functional Magnetic Resonance Imaging (fMRI) Exploration of Neurocognitive Processes Involved in Food Addiction (FA) in · Phase 2, PHASE3 · completed
- NCT04129801 — Muscle Strength in Severe Obese Patients in the Postoperative of Bariatric Surgery · completed
Other recruiting trials for Hemodialysis Complication
Currently open trials in the same condition.
- NCT07386691 — Comparing Effect of Intradialytic Aerobic Exercise Versus Incentive Spirometer on Fatigue and Sleep Quality Among Hemodi · NA · active not recruiting
- NCT07512895 — The Effect of Progressive Muscle Relaxation Exercises on Depression and Fatigue in Patients Receiving Hemodialysis Treat · NA · recruiting
- NCT07047547 — A Study of Real-world Events of Vericiguat in Patients With Chronic Kidney Disease and Heart Failure · NA · recruiting
- NCT06452563 — Amino Acids Supplementation and Exercise Intervention in Hemodialysis Patients · Phase 4 · active not recruiting
- NCT06520631 — Response Of Arteriovenous Fistula Puncture-related Pain To Cryotherapy Application In Haemodialysis Patients · NA · recruiting
Other Cishan Hospital, Ministry of Health and Welfare trials
Trials by the same sponsor.
- NCT07513025 — Effectiveness of RPT With Elastic Band in Tx of Sarcopenia in LTCFs · NA · completed
- NCT07492849 — Prevalence of Sarcopenia in Stroke Patients · completed
- NCT05360667 — Using Exergame-based Program in Elders of Rural LTCF · NA · completed
- NCT03809104 — VR-based Rehabilitation in the Treatment and Prevention of Sarcopenia of Older Residents · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06573567 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cishan Hospital, Ministry of Health and Welfare
- Last refreshed: 13 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06573567.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing